Interaction With the Lipid Membrane Influences Fentanyl Pharmacology
Advances in Drug and Alcohol Research · 21.03.2022 · 2
DOI: 10.3389/adar.2022.10280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Drug and Alcohol Research, online erschienen am 21.03.2022. Verfasst von Katy J Sutcliffe und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, Bristol, United Kingdom. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Overdose deaths from fentanyl have reached epidemic proportions in the USA and are increasing worldwide. Fentanyl is a potent opioid agonist that is less well reversed by naloxone than morphine. Due to fentanyl’s high lipophilicity and elongated structure we hypothesised that its unusual pharmacology may be explained by its interactions with the lipid membrane on route to binding to the µ-opioid receptor (MOPr). Through coarse-grained molecular dynamics simulations, electrophysiological recordings and cell signalling assays, we determined how fentanyl and morphine access the orthosteric pocket of MOPr. Morphine accesses MOPr via the aqueous pathway; first binding to an extracellular vestibule, then diffusing into the orthosteric pocket. In contrast, fentanyl may take a novel route; first partitioning into the membrane, before accessing the orthosteric site by diffusing through a ligand-induced gap between the transmembrane helices. In electrophysiological recordings fentanyl-induced currents returned after washout, suggesting fentanyl deposits in the lipid membrane. However, mutation of residues forming the potential MOPr transmembrane access site did not alter fentanyl’s pharmacological profile in vitro . A high local concentration of fentanyl in the lipid membrane, possibly in combination with a novel lipophilic binding route, may explain the high potency and lower susceptibility of fentanyl to reversal by naloxone.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, Bristol, United Kingdom.
- Department of Biochemistry, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
- Department of Pharmacy and Pharmacology, Faculty of Science, University of Bath, Bath, United Kingdom.
- Macquarie Medical School, Macquarie University, Sydney, NSW, Australia.
- Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
- School of Biochemistry, Faculty of Life Sciences, University of Bristol, Bristol, United Kingdom.
Förderung
- Medical Research Council
Zitieren
APA
Sutcliffe, K. J., Corey, R. A., Alhosan, N., Cavallo, D., Groom, S., Santiago, M., Bailey, C., Charlton, S. J., Sessions, R. B., Henderson, G., & Kelly, E. (2022). Interaction With the Lipid Membrane Influences Fentanyl Pharmacology. Advances in Drug and Alcohol Research, 2. https://doi.org/10.3389/adar.2022.10280
Vancouver
Sutcliffe KJ, Corey RA, Alhosan N, Cavallo D, Groom S, Santiago M, et al. Interaction With the Lipid Membrane Influences Fentanyl Pharmacology. Advances in Drug and Alcohol Research. 2022;2. doi:10.3389/adar.2022.10280
BibTeX
@article{Sutcliffe2022,
author = {Sutcliffe, Katy J and Corey, Robin A and Alhosan, Norah and Cavallo, Damiana and Groom, Sam and Santiago, Marina and Bailey, Chris and Charlton, Steven J and Sessions, Richard B and Henderson, Graeme and Kelly, Eamonn},
title = {Interaction With the Lipid Membrane Influences Fentanyl Pharmacology},
journal = {Advances in Drug and Alcohol Research},
year = {2022},
volume = {2},
doi = {10.3389/adar.2022.10280}
}
EUVIMED